What are the common adverse reactions of Brivaracetam/Brivaracetam? How to prevent and treat

Brivaracetam/Brivaracetam is a new anti-epileptic drug mainly used to treat partial seizures of epilepsy, as a single drug or as an auxiliary drug. Although generally well tolerated, brivaracetam, like all CNS drugs, may cause a range of adverse effects, primarily neurological and psychobehavioral problems.

The most common adverse reactions include drowsiness, dizziness, fatigue and nausea. These symptoms usually occur in the early stages of treatment and can reduce as the body gradually adapts to the drug. Some patients may experience behavioral changes such as anxiety, depression, or irritability, and these reactions are more common in patients with a history of mental illness. In addition, there are individual reports that brivaracetam may induce aggressive behavior or self-injury tendencies, but the incidence is low. For people who drive, operate machinery, or work that require a high degree of alertness, special attention should be paid to assessing its impact on alertness and coordination during the initial period of medication.

The key to preventing adverse reactions lies in individualized treatment. When initiating brivaracetam, start with the recommended starting dose and titrate accordingly based on the patient's specific response. When combined with other anti-epileptic drugs, attention should also be paid to interactions, especially when used simultaneously with other central nervous system depressants, and caution should be taken to superimpose sedative effects. Doctors usually recommend that patients avoid drinking alcohol during the early stages of taking the drug because alcohol may aggravate the central depressant reaction.

If patients experience mild adverse reactions, they can take symptomatic treatment under the guidance of a doctor, such as adjusting the medication time, taking it in divided doses, or temporarily reducing the dose. When adverse reactions seriously affect the quality of life, or there are mood swings or self-injury tendencies, the drug should be stopped immediately and seek help from a psychiatrist or neurologist. Patients with a history of mood disorders should be evaluated before medication and followed up during treatment.

Reference materials:https://www.briviact.com/